alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 125 (Wednesday, July 1, 2009)]
[Notices]
[Page 31452]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15568]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel, RC2 Sequencing Technology.
    Date: July 27, 2009.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Washington Plaza Hotel, 10 Thomas Circle, NW., 
Washington, DC 20005.
    Contact Person: Ken D. Nakamura, PhD, Scientific Review Officer, 
Scientific Review Branch, National Human Genome Research Institute, 
National Institutes of Health, 5635 Fishers Lane, Suite 4076, MSC 
9306, Rockville, MD 20852, 301-402-0838, <a href="/cdn-cgi/l/email-protection#92fcf3f9f3ffe7e0f9d2fff3fbfebcfcfbfabcf5fde4"><span class="__cf_email__" data-cfemail="6c020d070d01191e072c010d050042020504420b031a">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: June 24, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-15568 Filed 6-30-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Rail Employer Reporting Instructions

Part IV - Particular Types of Compensation Payments

Chapter 13: Selected Fringe Benefits

1

Group Term Life Insurance

The cost of group term life insurance is considered compensation under the Railroad Retirement 

Act to the extent that it is included in the gross income of an employee and subject to Railroad 

Retirement tax. The cost of group term life insurance with respect to periods within an 

employment relationship is treated the same as ordinary compensation creditable for both Tier I 

and Tier II purposes.

Group Term Life Insurance Reported on an Earned Basis

If compensation is reported on an earned basis, the cost of the group term life insurance with 

respect to periods after the termination of the employment relation should be reported to the 

month the employment relation ended, up to the applicable annual Tier I and Tier II maximums. 

If the maximum creditable Tier I amount has been received, additional amounts would be 

considered miscellaneous compensation under the conditions described in Part IV, Chapter 2.

Section 125 Cafeteria Plan

Cafeteria plans (flexible benefit plan) are benefit plans under which all participants are 

employees, who can choose from among cash and certain qualified benefits. If the employee 

elects qualified benefits, the employer contributions are excluded from creditable compensation. 

However, if an employee elects to receive cash instead of any qualified benefit, the cash payment 

is creditable compensation.

Section 401(k) Plan or Section 457 Plan

Employee contributions to Section 401(k) or Section 457 salary reduction plans are considered 

creditable railroad compensation at the time of contribution. Employer matching contributions 

are not considered compensation.

Authority Over Tax Questions

Representatives from the Railroad Retirement Board have no authority to give definitive answers 

to railroad retirement tax questions. Questions regarding railroad retirement taxes should be 

directed to the IRS at (913) 345-5622.
* This order and judgment is not binding precedent, except under the

doctrines of law of the case, res judicata, and collateral estoppel. The court

generally disfavors the citation of orders and judgments; nevertheless, an order

and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3. 

F I L E D

United States Court of Appeals

Tenth Circuit

JUN 23 1998

PATRICK FISHER

Clerk

UNITED STATES COURT OF APPEALS

FOR THE TENTH CIRCUIT

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

v.

WILLIAM L. GARRETT,

Defendant-Appellant.

No. 97-6407

(D.C. No. CR-97-13-A)

(W.D. Okla.)

ORDER AND JUDGMENT *

Before KELLY , BARRETT , and HENRY , Circuit Judges.

After examining the briefs and appellate record, this panel has determined

unanimously to grant the parties’ request for a decision on the briefs without oral

argument. See Fed. R. App. P. 34(f); 10th Cir. R. 34.1.9. The case is therefore

ordered submitted without oral argument. 
1 The amount of restitution ordered is not disputed on appeal, and does not

include any portion of the $120,000 that is disputed on appeal.

- 2 -

Defendant William L. Garrett appeals from the sentence imposed under

U.S.S.G. § 2F1.1 after he entered a plea of nolo contendere to ten counts of mail

fraud in violation of 18 U.S.C. §§ 1341 and 2. We dismiss the appeal as moot.

Defendant argues on appeal that a $120,000 loan should not have been

included as relevant conduct under U.S.S.G. § 1B1.3(a)(2) or in the total amount

of loss under § 2F1.1(b). Because the district court included the $120,000 in the

amount of loss, defendant’s offense level was calculated to be thirteen, which

called for a guideline range of 12-18 months’ imprisonment. Without the loan

amount, his offense level would have been ten, which would have resulted in a

guideline range of 6-12 months’ imprisonment. The district court sentenced

defendant to twelve months’ imprisonment to be followed by three years’

supervised release, and restitution in the amount of $24,500. 1

 See R. Vol. 4,

at 80-81. It stated:

The reason I imposed confinement for a period of twelve months is

[because] that is the overlapping quantum as between levels 13 and

level ten. And Mr. Garrett has every right to pursue, of course, if he

. . . decide[s] to appeal, the question of the amount of loss. And the

only significant aspect of that now is the $120,000 component of

that. And should he prevail on that issue, which certainly can

happen, then he would be at a Guideline level in which twelve

months was the maximum permitted.
- 3 -

Id. at 82-83. We believe this is a clear indication that defendant’s sentence would

be the same even if the loan amount were subtracted from relevant conduct, and

the appeal is therefore moot. Cf. United States v. Mondaine , 956 F.2d 939, 943

(10th Cir. 1992) (holding that appeal was not moot where district court did not

clearly state that sentence would be the same under either of two arguably

applicable guideline ranges); United States v. Urbanek , 930 F.2d 1512, 1515-16

(10th Cir. 1991) (same). 

DISMISSED as MOOT.

Entered for the Court

Paul J. Kelly, Jr.

Circuit Judge
# table153_q15.6_size
CAUSE NO. 03-14-00698-CV 

________________________________________ 

IN THE THIRD COURT OF APPEALS IN AUSTIN, TEXAS 

________________________________________ 

SHAMARK SMITH LIMITED PARTNERSHIP, ET AL., 

 Appellants, 

v. 

MARTIN LONGORIA, 

 Appellee. 

________________________________________ 

On appeal from the 20th Judicial District Court of Milam County, Texas 

________________________________________ 

SECOND UNOPPOSED MOTION FOR EXTENSION OF TIME TO FILE 

REPLY BRIEF 

________________________________________ 

Tracy J. Willi 

Texas Bar No. 00784633 

Willi Law Firm, P.C. 

9600 Escarpment Blvd., Suite 745, PMB 34 

Austin, TX 78749-1983 

Tel. (512) 288-3200 

Fax (512) 288-3202 

twilli@willi.com 

ATTORNEY FOR SHAMARK SMITH 

LIMITED PARTNERSHIP, SHARON D. 

MARCUS, AND PAUL J. SMITH 

ACCEPTED

03-14-00698-CV

6235663

THIRD COURT OF APPEALS

AUSTIN, TEXAS

7/27/2015 2:09:20 PM

JEFFREY D. KYLE

CLERK

 FILED IN 3rd COURT OF APPEALS AUSTIN, TEXAS 7/27/2015 2:09:20 PM JEFFREY D. KYLE Clerk
2 

SECOND UNOPPOSED MOTION FOR EXTENSION OF TIME TO FILE 

REPLY BRIEF 

Shamark Smith Limited Partnership, Sharon D. Marcus, and Paul J. Smith 

file this Second Unopposed Motion for Extension of Time to File Appellants’ 

Reply Brief. 

The trial court in this case entered judgment on August 15, 2014. The 

Appellee’s Brief was filed on June 5, 2015. The Appellants’ Reply Brief is due to 

be filed on July 27, 2015. While there have been previous extensions of time 

granted, this is the second request for an extension of time to file the Appellants’ 

Reply Brief. 

Due to intervening deadlines in other matters, there will not be sufficient 

time to complete the Appellants’ Reply Brief. Therefore, Appellants request that 

the deadline for the Reply Brief be extended from July 27, 2015 to August 26, 

2015. This motion is filed not for delay but so that justice can be done. 
3 

Respectfully submitted, 

/s/ Tracy J. Willi 

Tracy J. Willi 

Texas Bar No. 00784633 

Willi Law Firm, P.C. 

9600 Escarpment Blvd., Suite 745, PMB 34 

Austin, TX 78749-1983 

Tel. (512) 288-3200 

Fax (512) 288-3202 

twilli@willi.com 

ATTORNEY FOR SHAMARK SMITH 

LIMITED PARTNERSHIP, SHARON D. 

MARCUS, AND PAUL J. SMITH 

CERTIFICATE OF CONFERENCE 

I hereby certify that I conferred with opposing counsel, James David 

Walker, and he is not opposed to this motion. 

/s/ Tracy J. Willi 

Tracy J. Willi 
4 

CERTIFICATE OF FILING AND SERVICE 

I hereby certify that this document was filed with Clerk of Court through the 

Court’s electronic filing system (“efs”) and served on all counsel of record by 

email on July 27, 2015 as follows: 

James David Walker 

P.O. Box 41 

Milano, Texas 76556 

(512) 636-9520 

(512) 455-7992 (fax) 

walker@2appeal.com 

ATTORNEY FOR MARTIN M. LONGORIA 

/s/ Tracy J. Willi 

Tracy J. Willi
Exhibit 31.2

 

**CERTIFICATION PURSUANT TO SECTION 302**

**OF THE SARBANES-OXLEY ACT OF 2002**

** **

I, Jeff Cauble, certify that:

| 1. | I have reviewed this annual report on Form 10-K/A of Cesca Therapeutics Inc.; |
|----|-------------------------------------------------------------------------------|

| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

|                    |   |   | Cesca Therapeutics Inc.                     |
|-------------------------|--------|--------|---------------------------------------------|
|                    |   |   |                                        |
|                    |   |   |                                        |
| Dated: October 20, 2017 |   | By:/s/ | Jeff Cauble                                 |
|                    |   |   | Principal Financial and Accounting

Officer |
EX-32
  ·   Section 1350 Certifications




GENEMEN
INC.





Pursuant
to Section  18U.S.C.  Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant  to  section  906  of  the   Sarbanes-Oxley   Act  of  2002
(subsection  (a) and (b)
of  section  1350,  chapter 63 of title 18,
United  States  Code),  each of
the  undersigned  officers  of Genemen
Inc.,  a Nevada  corporation (the "Company"), does hereby
certify that:





The
Annual  Report of Form 10-Q for the quarter ended  November
30, 2008  (the  "Form  10-Q")  of  the  Company   fully   complies   with  the
requirements  of section 13(a) or 15(d) of
the  Securities  Exchange  Act of
1934  and  information  contained  in
the  Form  10-Q  fairly presents,  in
all
material  respects,  the  financial  condition
and results of operations of the Company.








Date:
February 8, 2009





/s/ Qiaozhen
Chen


Qiaozhen
Chen


Principal
Executive Officer


and
Principal Financial Officer
UNITED STATES DISTRICT COURT

DISTRICT OF NEW JERSEY

INTEGRATED ORTHOPEDICS, INC.,

on behalf of itself and a certified class of 

others similarly situated,

Plaintiff,

v.

UNITEDHEALTH GROUP, et al., 

Defendants.

No. 11-cv-425 (ES)(CLW)

Filing Date: February 18, 2021

Motion Date: February 25, 2021

NOTICE OF MOTION FOR FINAL APPROVAL OF CLASS 

SETTLEMENT, INCLUDING ATTORNEYS’ FEES AND COSTS, AND 

SERVICE AWARD FOR CLASS REPRESENTATIVE

PLEASE TAKE NOTICE that on February 25, 2021, or as soon thereafter 

as counsel can be heard, Plaintiff, by counsel, will move the Court for entry of an 

Order granting final approval to the class action settlement in the above-captioned 

case, including attorneys’ fees and costs, and a service award for the Class 

Representative, as fair, reasonable, and adequate under Rule 23 of the Federal 

Rules of Civil Procedure. 

PLEASE TAKE FURTHER NOTICE that in support of this motion, 

Plaintiff will rely on the Memorandum of Law in Support of Plaintiff’s Motion 

for Final Approval of Class Settlement, Including Attorneys’ Fees and Costs, and 

Case 2:11-cv-00425-ES-CLW Document 430 Filed 02/18/21 Page 1 of 2 PageID: 20056
2

Service Award for Class Representative, and the Declaration of Andrew N. 

Goldfarb in support thereof. 

PLEASE TAKE FURTHER NOTICE that a proposed Final Approval 

Order and Judgment is also submitted herewith.

Dated: February 18, 2021 /s/ John W. Leardi 

John W. Leardi

Vincent N. Buttaci

Paul D. Werner

BUTTACI LEARDI & WERNER LLC

212 Carnegie Center, Suite 202

Princeton, NJ 08540

609-799-5150

D. Brian Hufford

Jason S. Cowart

ZUCKERMAN SPAEDER LLP

485 Madison Avenue, 10th Fl.

New York, NY 10022

212-704-9600

Andrew N. Goldfarb

ZUCKERMAN SPAEDER LLP

1800 M Street, NW, Suite 1000

Washington, DC 20036

202-778-1800

Anthony F. Maul 

THE MAUL FIRM, P.C.

101 Broadway, Suite 3A

Oakland, CA 94607 

510-496-4477

Attorneys for Plaintiff

Case 2:11-cv-00425-ES-CLW Document 430 Filed 02/18/21 Page 2 of 2 PageID: 20057
[Federal Register Volume 74, Number 130 (Thursday, July 9, 2009)]
[Notices]
[Pages 32953-32954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-16018]


=======================================================================
-----------------------------------------------------------------------

JUDICIAL CONFERENCE OF THE UNITED STATES


Meeting of the Judicial Conference Advisory Committee on Rules of 
Civil Procedure

AGENCY: Judicial Conference of the United States Advisory Committee on 
Rules of Civil Procedure.

ACTION: Notice of Open Meeting.

-----------------------------------------------------------------------

SUMMARY: The Advisory Committee on Rules of Civil Procedure will hold a 
two-day meeting. The meeting will be open to public observation but not 
participation.

DATES: October 8-9, 2009.
    Time: 8:30 a.m. to 5 p.m.

ADDRESSES: Georgetown University Law Center, 600 New Jersey Avenue, 
NW., Washington, DC 20001.

FOR FURTHER INFORMATION CONTACT: John K. Rabiej, Chief, Rules Committee 
Support Office, Administrative Office of the United States Courts, 
Washington, DC 20544, telephone (202) 502-1820.


[[Page 32954]]


    Dated: July 1, 2009.
John K. Rabiej,
Chief, Rules Committee Support Office.
[FR Doc. E9-16018 Filed 7-8-09; 8:45 am]
BILLING CODE 2210-55-M
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Market Data Consultants, Inc. (the "Company") on Form 10-QSB for the period ended November 30, 2006 (the "Report"), I, Wilson Cheung, President and Chairman of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

> 1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange
> Act of 1934; and
> 
> 
> 2) The information contained in the Report fairly presents, in all material respects, the Company's
> financial position and results of operations.

/s/Wilson Cheung



Wilson Cheung, President and Chairman

January 12, 2007
[Federal Register Volume 74, Number 131 (Friday, July 10, 2009)]
[Notices]
[Page 33268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-16066]



[[Page 33268]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; LRP Application.
    Date: July 10, 2009.
    Time: 9 a.m. to 10 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Blvd, 
Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Lyle Furr, Contract Review Specialist, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program No. 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: July 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-16066 Filed 7-9-09; 8:45 am]
BILLING CODE 4140-01-M
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 693 Engrossed in House (EH)]

<DOC>
H. Res. 693

                In the House of Representatives, U. S.,

                                                     November 14, 2019.
    Resolved, That, pursuant to regulations issued by the Committee on House 
Administration--
            (1) the Director of the Office of Diversity and Inclusion 
        established under section 104(d) of House Resolution 6 may appoint and 
        fix the pay of employees of the Office; and
            (2) the Director of the Office of the Whistleblower Ombudsman 
        established under section 104(e) of House Resolution 6 may appoint and 
        fix the pay of employees of the Office.
            Attest:

                                                                          Clerk.
```
2012 10K EX 10.16(iii)


EXHIBIT 10.16(iii)


Second Amendment
to Executive Severance Letter


This Amendment, made this 18th day of December, 2012, amends that certain Executive Severance Letter, dated as of May 7, 2009, as heretofore amended, (the “Agreement”) between Duke Realty Corporation (the “Company”) and Christie B. Kelly (“Executive”).


The parties have determined that it is in their best interests to amend the Agreement to include special provisions intended to ensure compliance with Internal Revenue Code Section 409A relating to the timing of a release of claims.  In consideration of the mutual covenants contained herein and the continued employment of Executive by the Company, the parties agree as follows:


		
	1.
	The Agreement is hereby amended by deleting numbered paragraph 4 under the caption “Obligations” in its entirety and substituting therefore the following:




“4.  The payments and benefits under this agreement are conditioned upon your execution and non-revocation of a General Release of All Claims and Covenant Not to Sue, in the form in general use by the Company as of the time of your separation from employment (the “Release”).  The Release (i) must be presented by the Company to you within 7 days after your separation of employment and (ii) must be executed by you, and all revocation periods shall have expired, within 60 days after your separation from employment; failing which such payments or benefits shall be forfeited.  If such 60-day period spans two calendar years, the payment or benefit shall not be made or commence before the second such calendar year, even if the Release becomes irrevocable in the first such calendar year.  In other words, you are not permitted to influence the calendar year of payment based on the timing of your signing of the Release.”
 
		
	2.
	Except as expressly amended hereby, the terms of the Agreement shall be and remain unchanged and the Agreement as amended hereby shall remain in full force and effect.  The parties are authorized to restate the entire Agreement as amended hereby.




IN WITNESS WHEREOF, the Company and Executive have caused this Amendment to be duly executed.


DUKE REALTY CORPORATION




By:     /s/    Dennis D. Oklak

Dennis D. Oklak
Chairman and Chief Executive Officer




EXECUTIVE
/s/    Christie B. Kelly 
Christie B. Kelly
Motion Granted; Appeal Dismissed and Memorandum Opinion filed

February 25 , 2014

.

In The



## Fourteenth Court of Appeals

NO. 14

- 13

- 01110

- CV

SHEILA VOGEL, INDIVI DUALLY AND AS NEXT F RIEND OF SARA

VOGEL, A MINOR , Appellant

V.

DARREN MILLER AND CH LOE MILLER , Appellee s

On Appeal from the 190th District Court

Harris County, Texas Trial Court Cause No. 2011

- 01297

M E M O R A N D U M O P I N I O N This is an appeal from a judgment signed September 20, 2013 . On February 6, 2014, appellant filed a motion to dismiss the appeal. S ee Tex. R. App. P. 42.1. The motion is granted.
Accordingly, the appeal is ordered dismissed.

PER CURIAM

Panel consists of Chief Justice Frost and Justices Jamison and Wise.
[Federal Register Volume 74, Number 127 (Monday, July 6, 2009)]
[Notices]
[Page 31981]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15767]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-71,006]


Endless Summer, Inc., 2503 North Neergard, Springfield, MO; 
Notice of Termination of Investigation

    Pursuant to Section 223 of the Trade Act of 1974, as amended, an 
investigation was initiated on June 5, 2009 in response to a worker 
petition filed on behalf of workers of Endless Summer, Inc., 
Springfield, Missouri.
    The petitioning group of workers is covered by an earlier petition 
(TA-W-71,003) filed on June 5, 2009 that is the subject of an ongoing 
investigation for which a determination has not yet been issued. 
Consequently, further investigation in this case would serve no 
purpose, and the investigation under this petition has been terminated.

    Signed at Washington, DC, this 11th day of June 2009.
Richard Church,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E9-15767 Filed 7-2-09; 8:45 am]
BILLING CODE 4510-FN-P